Influenza A (H1N1) 2009 Monovalent
FDA approved these vaccines as a strain change to each manufacturer’s seasonal influenza vaccine. There is considerable experience with seasonal influenza vaccine development and production and influenza vaccines produced by this technology have a long and successful track record of safety and effectiveness in the United States. The Influenza A (H1N1) 2009 Monovalent vaccines will undergo the usual testing and lot release procedures that are in place for seasonal influenza vaccines.
Injectable Vaccines
- Influenza A (H1N1) 2009 Monovalent Vaccine (CSL Limited)
- Influenza A (H1N1) 2009 Monovalent Vaccine (ID Biomedical Corporation of Quebec)
- Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis Vaccines and Diagnostics Limited)
- Influenza A (H1N1) 2009 Monovalent Vaccine (Sanofi Pasteur, Inc.)
Intranasal Vaccine
Key Resources
- Influenza A (H1N1) 2009 Monovalent Vaccine Live, Intranasal Questions and Answers
- Influenza A (H1N1) 2009 Monovalent Vaccines Questions and Answers
- Use of Influenza A (H1N1) 2009 Monovalent Influenza Vaccine in Pregnant Women
- Influenza A (H1N1) 2009 Monovalent Vaccines Composition and Lot Release
- Influenza A (H1N1) 2009 Monovalent Vaccines Descriptions and Ingredients
- Influenza A (H1N1) 2009 Monovalent Vaccine Safety Monitoring
- Guidance for Industry: Recommendations for Blood Establishments: Training of Back-Up Personnel, Assessment of Blood Donor Suitability and Reporting Certain Changes to an Approved Application
- 2009 H1N1 (Swine) Flu Virus (Biologics)